Article Information
PMID
Published By
Print ISSN
0250-7005
Online ISSN
1791-7530
History
- Received July 12, 2016
- Revision received July 19, 2016
- Accepted July 20, 2016
- Published online September 14, 2016.
Copyright & Usage
Copyright© 2016 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved
Author Information
- IGOR KISS1⇑,
- JITKA MLCOCHOVA2,
- ZBYNEK BORTLICEK3,
- ALEXANDR POPRACH1,
- JIRI DRABEK4,
- PETRA VYCHYTILOVA-FALTEJSKOVA1,2,
- MAREK SVOBODA1,2,
- TOMAS BUCHLER5,
- STANISLAV BATKO6,
- ALES RYSKA7,
- MARIAN HAJDUCH4 and
- ONDREJ SLABY1,2⇑
- 1Department of Comprehensive Cancer Care, Masaryk Memorial Cancer Institute, Brno, Czech Republic
- 2Central European Institute of Technology, Masaryk University, Brno, Czech Republic
- 3Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Brno, Czech Republic
- 4Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University Olomouc, Olomouc, Czech Republic
- 5Department of Oncology, Thomayer Hospital and Charles University First Faculty of Medicine, Prague, Czech Republic
- 6Department of Oncology, Motol University Hospital and Charles University Second Faculty of Medicine, Prague, Czech Republic
- 7The Fingerland Department of Pathology, Charles University Medical Faculty Hospital, Hradec Kralove, Czech Republic
- Correspondence to: Igor Kiss, MD, Ph.D., Department of Comprehensive Cancer Care, Masaryk Memorial Cancer Institute, Zluty kopec 7, 656 53 Brno, Czech Republic. Tel: +420 543131111, e-mail: kiss{at}mou.cz and Assoc. Prof. Ondrej Slaby, PhD, Central European Institute of Technology (CEITEC), Masaryk University, University Campus Bohunice, Building A35, Room 217, Kamenice 5, 625 00 Brno, Czech Republic. Tel: +420 776494155, e-mail: on.slaby{at}gmail.com
